Literature DB >> 17303688

Preanalytic influence of sample handling on SELDI-TOF serum protein profiles.

John F Timms1, Elif Arslan-Low, Aleksandra Gentry-Maharaj, Zhiyuan Luo, Davy T'Jampens, Vladimir N Podust, Jeremy Ford, Eric T Fung, Alex Gammerman, Ian Jacobs, Usha Menon.   

Abstract

BACKGROUND: High-throughput proteomic methods for disease biomarker discovery in human serum are promising, but concerns exist regarding reproducibility of results and variability introduced by sample handling. This study investigated the influence of different preanalytic handling methods on surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) protein profiles of prefractionated serum. We investigated whether older collections with longer sample transit times yield useful protein profiles, and sought to establish the most feasible collection methods for future clinical proteomic studies.
METHODS: To examine the effect of tube type, clotting time, transport/incubation time, temperature, and storage method on protein profiles, we used 6 different handling methods to collect sera from 25 healthy volunteers. We used a high-throughput, prefractionation strategy to generate anion-exchange fractions and examined their protein profiles on CM10, IMAC30-Cu, and H50 arrays by using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
RESULTS: Prolonged transport and incubation at room temperature generated low mass peaks, resulting in distinctions among the protocols. The most and least stringent methods gave the lowest overall peak variances, indicating that proteolysis in the latter may have been nearly complete. For samples transported on ice there was little effect of clotting time, storage method, or transit time. Certain proteins (TTR, ApoCI, and transferrin) were unaffected by handling, but others (ITIH4 and hemoglobin beta) displayed significant variability.
CONCLUSIONS: Changes in preanalytical handling variables affect profiles of serum proteins, including proposed disease biomarkers. Proteomic analysis of samples from serum banks collected using less stringent protocols is applicable if all samples are handled identically.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17303688     DOI: 10.1373/clinchem.2006.080101

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  48 in total

1.  Translational research: current status, challenges and future strategies.

Authors:  Dale Yu
Journal:  Am J Transl Res       Date:  2011-09-12       Impact factor: 4.060

2.  Optimization of MALDI-TOF MS detection for enhanced sensitivity of affinity-captured proteins spanning a 100 kDa mass range.

Authors:  Christine L Gatlin-Bunai; Lisa H Cazares; William E Cooke; Oliver J Semmes; Dariya I Malyarenko
Journal:  J Proteome Res       Date:  2007-10-05       Impact factor: 4.466

3.  Biobanking and international interoperability: samples.

Authors:  Michael Kiehntopf; Michael Krawczak
Journal:  Hum Genet       Date:  2011-07-15       Impact factor: 4.132

Review 4.  Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.

Authors:  Muriel De Bock; Dominique de Seny; Marie-Alice Meuwis; Jean-Paul Chapelle; Edouard Louis; Michel Malaise; Marie-Paule Merville; Marianne Fillet
Journal:  J Biomed Biotechnol       Date:  2009-12-06

5.  Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group.

Authors:  Melissa K Tuck; Daniel W Chan; David Chia; Andrew K Godwin; William E Grizzle; Karl E Krueger; William Rom; Martin Sanda; Lynn Sorbara; Sanford Stass; Wendy Wang; Dean E Brenner
Journal:  J Proteome Res       Date:  2009-01       Impact factor: 4.466

6.  Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias.

Authors:  Dale McLerran; William E Grizzle; Ziding Feng; William L Bigbee; Lionel L Banez; Lisa H Cazares; Daniel W Chan; Jose Diaz; Elzbieta Izbicka; Jacob Kagan; David E Malehorn; Gunjan Malik; Denise Oelschlager; Alan Partin; Timothy Randolph; Nicole Rosenzweig; Shiv Srivastava; Sudhir Srivastava; Ian M Thompson; Mark Thornquist; Dean Troyer; Yutaka Yasui; Zhen Zhang; Liu Zhu; O John Semmes
Journal:  Clin Chem       Date:  2007-11-02       Impact factor: 8.327

7.  Optimizing sample handling for urinary proteomics.

Authors:  Richard S Lee; Flavio Monigatti; Andrew C Briscoe; Zachary Waldon; Michael R Freeman; Hanno Steen
Journal:  J Proteome Res       Date:  2008-07-29       Impact factor: 4.466

8.  Application of mass spectrometry-based proteomics for biomarker discovery in neurological disorders.

Authors:  Abhilash Venugopal; Raghothama Chaerkady; Akhilesh Pandey
Journal:  Ann Indian Acad Neurol       Date:  2009-01       Impact factor: 1.383

9.  Proteomics: challenges, techniques and possibilities to overcome biological sample complexity.

Authors:  Kondethimmanahalli Chandramouli; Pei-Yuan Qian
Journal:  Hum Genomics Proteomics       Date:  2009-12-08

10.  Limitations in SELDI-TOF MS whole serum proteomic profiling with IMAC surface to specifically detect colorectal cancer.

Authors:  Qi Wang; Jing Shen; Zhen-fu Li; Jian-zheng Jie; Wen-yue Wang; Jin Wang; Zhong-tao Zhang; Zhi-xia Li; Li Yan; Jin Gu
Journal:  BMC Cancer       Date:  2009-08-19       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.